Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription 22.09.2025 1 Am J Clin Nutr 1 Am J Manag Care 2 Ann Intern Med 4 Biochem Biophys Res Commun 1 BMC Pediatr 7 Diabet Med 1 Diabetes 3 Diabetes Care 8 Diabetes Obes Metab 4 Diabetologia 1 Invest Ophthalmol Vis Sci 2 J Am Coll Cardiol 1 J Autoimmun 2 J Diabetes Complications 2 J Pediatr 3 Med Care 1 Nature 1 Pediatr Diabetes 1 PLoS Med 4 PLoS One 1 Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Nutr

1. GENG Y, Gu S, Fan Y, Lu X, et al
   Weight-adjusted-waist index, estimated glucose disposal rate, C-reactive protein, and mortality risks among individuals with type 2 diabetes: two prospective cohort studies in China and the UK.
   Am J Clin Nutr. 2025 Sep 13:S0002-9165(25)00535.
   PubMed         Abstract available
   
   

   
   Am J Manag Care

2. KAUR M, Ives B, Mijanovich T, Singh P, et al
   Workforce innovation reduces Medicaid costs in chronic care.
   Am J Manag Care. 2025;31.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

3. WEITZ HH, Merli GJ
   Annals Consult Guys - Diabetes Issues in Ambulatory Surgery.
   Ann Intern Med. 2025;178:e2504052CG.
   PubMed        
   
   
4. ADES M, Anand SS
   In symptomatic peripheral artery disease with T2D, semaglutide increased maximum walking distance at 1 y.
   Ann Intern Med. 2025;178:JC100.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

5. ZHOU H, Qiao J, Su H, Guo J, et al
   Silibinin accelerates diabetic wound healing through PI3K/Akt-mediated immunomodulation-angiogenesis crosstalk.
   Biochem Biophys Res Commun. 2025;784:152649.
   PubMed         Abstract available
   
   
6. CHHABRIA S, Mathur S, Vadakan S, Goswami D, et al
   Sennoside A from Cassia angustifolia as a mixed-type inhibitor of DPP-IV: Integrative in vitro, in silico, and kinetic characterization.
   Biochem Biophys Res Commun. 2025;781:152463.
   PubMed         Abstract available
   
   
7. MARIAM Z, Abolhasan MR, Reynolds CA, Yousefi R, et al
   Computational assessment of the dimeric incretin GLP-1cpGLP-1 reveals the structural bases for its activity.
   Biochem Biophys Res Commun. 2025;781:152525.
   PubMed         Abstract available
   
   
8. ZHANG X, Xia M, Liu Y, Yang M, et al
   Multi-omics profiling reveals liver-retina axis in high-fat diet-induced early retinopathy.
   Biochem Biophys Res Commun. 2025;781:152516.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

9. ATWA HA, Hemeda MS, Farh RM, Khafagy AA, et al
   Hair levels of mercury, lead, and cadmium and their association with glycemic control in Egyptian children with type 1 diabetes.
   BMC Pediatr. 2025;25:680.
   PubMed         Abstract available
   
   

   
   Diabet Med

10. CAMPBELL MS, Monzon A, McDonough RJ, Patton SR, et al
    Parent sleep quality and fear of nighttime hypoglycaemia.
    Diabet Med. 2025;42:e70110.
    PubMed         Abstract available
    
    
11. THABIT H, Lim J, Willinska ME, Fullwood C, et al
    Fully closed-loop control with ultra-rapid versus standard insulin lispro: A randomised crossover study simulating missed meal boluses.
    Diabet Med. 2025;42:e70122.
    PubMed         Abstract available
    
    
12. CHIAM G, Smith S, Tu T, Din A, et al
    A systematic review of outcomes measured in interventional trials in people with diabetic sensorimotor polyneuropathy.
    Diabet Med. 2025 Sep 12:e70134. doi: 10.1111/dme.70134.
    PubMed         Abstract available
    
    
13. HARRISON A, Zaremba N, Brown J, Pillay D, et al
    A quantitative process evaluation of a feasibility randomised controlled trial of a co-designed cognitive behavioural therapy intervention for people with type 1 diabetes and disordered eating (steady trial): Auditing treatment integrity and delivery.
    Diabet Med. 2025 Sep 12:e70124. doi: 10.1111/dme.70124.
    PubMed         Abstract available
    
    
14. DEN BROK EJ, Hornborg-Svensson C, Dimitropoulou NM, Broeng-Mikkelgaard S, et al
    Study protocol for exploring diabetes numeracy and health literacy across Europe (EDUCATE): A multicentre cross-sectional study.
    Diabet Med. 2025 Sep 18:e70140. doi: 10.1111/dme.70140.
    PubMed         Abstract available
    
    
15. MANTOVANI M, Kwiendacz H, Irlik K, Bucci T, et al
    Clinical risk phenotypes in diabetes and their associations with adverse cardiovascular events: A report from the Silesia Diabetes-Heart Project.
    Diabet Med. 2025 Sep 18:e70136. doi: 10.1111/dme.70136.
    PubMed         Abstract available
    
    
16. WANG J, Li XQ, Sun RL, Yang YH, et al
    Advanced glycation end products mediated diabetic neuropathic pain via activation protein tyrosine phosphatase 1B in the spinal cord dorsal horn.
    Diabet Med. 2025 Sep 18:e70141. doi: 10.1111/dme.70141.
    PubMed         Abstract available
    
    

    
    Diabetes

17. CARTER RD, Purnama U, Castro-Guarda M, Montes-Aparicio CN, et al
    Systems Biology and Functional Assessments of Human iPSC-Cardiomyocyte Models of Insulin Resistance Capture Key Hallmarks of Diabetic Cardiomyopathy.
    Diabetes. 2025 Sep 16:db250204. doi: 10.2337/db25-0204.
    PubMed         Abstract available
    
    

    
    Diabetes Care

18. HIRSCH IB, Kudva YC, Ahn DT, Blevins T, et al
    Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery Irrespective of C-Peptide Level.
    Diabetes Care. 2025 Sep 15:dc251125. doi: 10.2337/dc25-1125.
    PubMed         Abstract available
    
    
19. APPLEBAUM SS, Deng Y, Fu JJ, Kane M, et al
    Risk Factors and Consequences of Lapses in Proliferative Diabetic Retinopathy Care in a National Cohort.
    Diabetes Care. 2025 Sep 16:dc251202. doi: 10.2337/dc25-1202.
    PubMed         Abstract available
    
    
20. ALVAREZ C, Hirschler V, Calliari LE, Barrientos M, et al
    Delays in Access to Innovative Diabetes Therapies: A Persistent Inequity in Latin America.
    Diabetes Care. 2025 Sep 17:dc252005. doi: 10.2337/dc25-2005.
    PubMed        
    
    

    
    Diabetes Obes Metab

21. XUE X, Li J, Zheng W, Zhang B, et al
    Contributions of 2-h post-load glucose, fasting blood glucose and glycosylated haemoglobin elevations to the prevalence of diabetes and pre-diabetes in adults: A systematic analysis of global data.
    Diabetes Obes Metab. 2025 Sep 15. doi: 10.1111/dom.70130.
    PubMed         Abstract available
    
    
22. HOO JX, Yang YF, Lau ESH, Ibrahim L, et al
    A 7-year prospective analysis of sustained benefits of multicomponent risk assessment and data-driven care in patients with type 2 diabetes: The Malaysian JADE Program.
    Diabetes Obes Metab. 2025 Sep 15. doi: 10.1111/dom.70125.
    PubMed         Abstract available
    
    
23. LEE BW, Lee CB, Lim S, Kim SG, et al
    Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3.
    Diabetes Obes Metab. 2025 Sep 15. doi: 10.1111/dom.70111.
    PubMed         Abstract available
    
    
24. GURUNG RL, Zheng H, Tan JLI, Liu S, et al
    Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger-onset type 2 diabetes.
    Diabetes Obes Metab. 2025 Sep 18. doi: 10.1111/dom.70153.
    PubMed         Abstract available
    
    
25. MURUGAVEL S, Retnakaran R, Feig DS, Zinman B, et al
    Empagliflozin for the preservation of beta-cell function in women with recent gestational diabetes: A randomized placebo-controlled trial.
    Diabetes Obes Metab. 2025 Sep 18. doi: 10.1111/dom.70146.
    PubMed         Abstract available
    
    
26. LI X, Zhang Y, Bi Y, Lu J, et al
    Dapagliflozin restores odour-induced functional integration of primary olfactory cortex circuit but not olfactory-related regional brain activation in patients with type 2 diabetes: A 16-week randomised comparative study.
    Diabetes Obes Metab. 2025 Sep 15. doi: 10.1111/dom.70132.
    PubMed         Abstract available
    
    
27. CRUTCHLOW M, Liu J, Romero C, Watkins E, et al
    Combined agonism of nutrient receptors GPR40 and GPR119 with K-757 and K-833 results in weight loss and blood pressure reductions in obese subjects without type 2 diabetes mellitus.
    Diabetes Obes Metab. 2025 Sep 15. doi: 10.1111/dom.70120.
    PubMed         Abstract available
    
    
28. LI J, Liu Y, Xing W, Jiang Y, et al
    Blood glucose trajectories in diabetes patients receiving CAPDCA model of personalised patient education: A cluster randomised controlled trial.
    Diabetes Obes Metab. 2025 Sep 14. doi: 10.1111/dom.70119.
    PubMed         Abstract available
    
    

    
    Diabetologia

29. DIMITROPOULOU NM, Eussen SJPM, Schalkwijk CG, de Galan BE, et al
    Glucose variability measured by continuous glucose monitoring is associated with skin autofluorescence: the Maastricht Study.
    Diabetologia. 2025;68:1937-1946.
    PubMed         Abstract available
    
    
30. BRISNOVALI NF, Franco I, Abdelgawwad A, Tsou HLP, et al
    Effects of SGLT2 ablation or inhibition on corticosterone secretion in high-fat-fed mice: exploring a nexus with cytokine levels.
    Diabetologia. 2025;68:2042-2056.
    PubMed         Abstract available
    
    
31. GOMEZ-MEDINA AM, Henao-Carillo DC, Villamil-Castaneda LP, Gomez-Quesada Y, et al
    Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial.
    Diabetologia. 2025;68:1899-1907.
    PubMed         Abstract available
    
    
32. HOYER KL, Kornum DS, Baunwall SMD, Klinge MW, et al
    Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy.
    Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06544.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

33. HE Z, Peng X, Feng Y, Li Z, et al
    LINC02099 Promotes Retinal Extracellular Matrix Deposition in Diabetic Mice Via the miRNA-214-3p/CTSS Axis.
    Invest Ophthalmol Vis Sci. 2025;66:42.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

34. KRUMHOLZ HM, Inzucchi SE
    Beyond Adiposity: Embracing Complexity in Diabetes-Associated HFpEF.
    J Am Coll Cardiol. 2025 Sep 17:S0735-1097(25)07385.
    PubMed        
    
    
35. PACKER M, Lam CSP, Butler J, Zannad F, et al
    Is Type 2 Diabetes a Modifiable Risk Factor for the Evolution and Progression of Heart Failure With a Preserved Ejection Fraction?
    J Am Coll Cardiol. 2025 Sep 17:S0735-1097(25)07341.
    PubMed         Abstract available
    
    

    
    J Autoimmun

36. YI X, Zimath PL, Martin-Vazquez E, Oliveira JG, et al
    Transcriptomics of autoimmune diseases identifies FGFR1 as a target for pancreatic beta-cell protection.
    J Autoimmun. 2025;156:103469.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

37. XIE Z, Liang Z, Zheng G, Cao W, et al
    A comparative analysis of cost-utility: Chiglitazar vs. sitagliptin in patients with type 2 diabetes in China.
    J Diabetes Complications. 2025;39:109174.
    PubMed         Abstract available
    
    
38. RIZK MA, El-Haggar SM, Ibrahim OM, Ghazi HA, et al
    Efficacy of levocetirizine in reducing albuminuria and inflammatory biomarkers in patients with diabetic kidney disease: A randomized controlled trial.
    J Diabetes Complications. 2025;39:109175.
    PubMed         Abstract available
    
    

    
    J Pediatr

39. HALEY J, Woo JG, Jacobs DR Jr, Bazzano L, et al
    Corrigendum to: A Clinical Tool to Relate Youth Risk Factors to Adult Cardiovascular Events and Type 2 Diabetes: The i3C Consortium J. Pediatr. 2025 Jan;276:114277.
    J Pediatr. 2025 Sep 12:114782. doi: 10.1016/j.jpeds.2025.114782.
    PubMed        
    
    
40. VALDIVIA CAMACHO OD, Allison T, Wilson LB, Bellsmith K, et al
    Pediatric Cataracts as a Presenting Sign of Type 1 Diabetes Mellitus.
    J Pediatr. 2025 Sep 11:114806. doi: 10.1016/j.jpeds.2025.114806.
    PubMed         Abstract available
    
    

    
    Med Care

41. KNOX MJ, Hodgkin D, Slama NE, Sterling SA, et al
    Associations of Co-Occurring Substance Use Disorder With Diabetes Care Quality, Complications, and Hospitalizations.
    Med Care. 2025;63:443-448.
    PubMed         Abstract available
    
    
42. MANOUCHEHRI AMOLI M, Cunningham PJ, Masoud Bahnamiri M, Najafi MJ, et al
    The Effect of Medicaid Expansion on Care for Patients With Diabetes by Primary Care Provider Supply.
    Med Care. 2025;63:724-730.
    PubMed         Abstract available
    
    
43. WILSON IB, Gutman R, Lee Y, Dana BA, et al
    Impact of a Pharmacy Copayment Increase on Medication Use in the Military Health System.
    Med Care. 2025;63:731-739.
    PubMed         Abstract available
    
    

    
    Nature

44. 
    A plant-forward menu is linked to lower diabetes risk.
    Nature. 2025 Sep 17. doi: 10.1038/d41586-025-02992.
    PubMed        
    
    

    
    Pediatr Diabetes

45. MATUSZELANSKI D, Winiarczuk A, Tuszynski M, Wysocka-Mincewicz M, et al
    Seasonal Variation in Type 1 Diabetes Incidence in Poland: Exploring the Impact of Viral Infections, Including COVID-19.
    Pediatr Diabetes. 2025;2025:6868987.
    PubMed         Abstract available
    
    

    
    PLoS Med

46. SOWAH SA, Imamura F, Ibsen DB, Monsivais P, et al
    The association of the planetary health diet with type 2 diabetes incidence and greenhouse gas emissions: Findings from the EPIC-Norfolk prospective cohort study.
    PLoS Med. 2025;22:e1004633.
    PubMed         Abstract available
    
    

    
    PLoS One

47. MICHALEC J, Lustigova M, Fruhaufova A, Mala S, et al
    Prevalence and clustering of cardiovascular risk factors in a population aged 25-64 in Czechia: A cross-sectional study.
    PLoS One. 2025;20:e0332217.
    PubMed         Abstract available
    
    
48. SAINZ-PRADO R, Sainz-Prado A, Andrade-Gomez E, Rodriguez-Roca B, et al
    Quasi-experimental controlled study protocol to reduce sedentary lifestyle in patients with type 2 diabetes.
    PLoS One. 2025;20:e0330393.
    PubMed         Abstract available
    
    
49. FISCHER AK, Sadler A, Mathey E, Muhlbacher A, et al
    Analysis of patients preferences in type 2 diabetes mellitus second-line drug treatment: A discrete choice experiment.
    PLoS One. 2025;20:e0329743.
    PubMed         Abstract available
    
    
50. HEINSBERG LW, Loia M, Tasele S, Faasalele-Savusa K, et al
    Study protocol for the Health Outcomes in Pregnancy and Early Childhood (HOPE) Study: A mother-infant study in American Samoa.
    PLoS One. 2025;20:e0326644.
    PubMed         Abstract available
    
    

    
    Retina

51. SINA EM, Pena J, Zafar S, Bommakanti NK, et al
    Automated Machine Learning Classification of Optical Coherence Tomography Images of Retinal Conditions Using Google Cloud Vertex AI.
    Retina. 2025 Jun 11. doi: 10.1097/IAE.0000000000004555.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.